NCT05937217

Brief Summary

Postoperative scarring is one of the most common concerns among surgical patients. The incidence of abnormal scarring, i.e. keloid or hypertrophic scar formation after caesarean section (CS) is reported to be 41% .That can lead to functional limitations, pruritus, pain and cosmetic issues. so, the purpose of this study is to investigate quality of life and pain pressure threshold in response to myofascial induction and direct scar release techniques for lower transverse abdominal scar

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

July 5, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 10, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

July 14, 2023

Status Verified

July 1, 2023

Enrollment Period

3 months

First QC Date

June 30, 2023

Last Update Submit

July 12, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain pressure threshold (PPT)

    * A pressure algometer will be used to measure pressure pain threshold for all participating women in both groups. ● * PPT recording sites will be marked on the C-section scar at 2.5 cm intervals. This resulted in from 5 to 8 measurement points along the scar. * Following, the marked points will be used to record PPTs in all time points for the PPT assessment; a 1-cm2 pressure probe will be positioned perpendicularly to the skin and pressed at a rate of 30kPa/s.Two measures will be collected for each area, with 30 seconds rest between point testing . * Average pressure pain threshold (pressure points across worst 3 points on scar averaged) will be used to analyze the PPT data .

    within 4 weeks

  • scar mobility

    lower transverse abdominal scar mobility will be assessted by an adheremeter for both groups (A and B)before and after the end of treatment program. The adheremeter as described by Ferriero et al. has a radius of approximately 1.75 cm with concentric circles 2 mm apart . A mark will be made on the tightest part of the scar in four directions (superior, inferior, right and left). As there is no a contralateral side to abdominal tissue to be used as a reference range, we will use multi-directional scar mobility. Scar mobility measurements across the points will be averaged for each participating women and will be performed at the initial evaluation after 2 weeks (the end of the treatment) and at fourth week as follow up

    within 4 weeks

  • Patient and Observer Scar Assessment Scale (POSAS)

    It includes subjective symptoms of pain and pruritus. It consists of 2 numerical numeric scales,it assesses vascularity, pigmentation, thickness, relief, pliability, and surface area, and it incorporates patient assessments of pain, itching, color, stiffness, thickness, and relief . The observer scar assessment scale rated five variables, each variable used a 10-point scoring system, summed to obtain a total score ranging from 5 to 50, with 5 representing normal skin with no associated symptoms. The patient scar assessment scale consisted of six items on scar-related pain, itchiness, color, stiffness, thickness, and irregularity. Each item used a 10-point scoring system, summed to obtain a total score ranging from 6 to 60, with 6 representing normal skin with no associated symptoms.

    within 4 weeks

Secondary Outcomes (1)

  • quality of life assessment

    within 4 weeks

Study Arms (2)

myofascial induction and direct scar release techniques group

EXPERIMENTAL

They will receive myofascial induction therapy in the form of transverse sliding and cross hand therapy and direct scar release techniques in the form of stroking, circular movement, vertical point lifting , C and S grip techniques, and therapeutic ultrasound, 2 sessions per week for two weeks.

Other: myofascial induction and direct scar release techniquesDevice: therapeutic ultrasound

therapeutic ultrasound group

EXPERIMENTAL

They will receive a therapeutic ultrasound, 2 sessions per week for two weeks.

Device: therapeutic ultrasound

Interventions

Ultrasound petron (model SM 500) specifications: output frequency:1Mhz, output power:5W/cm², power intensity:5 degree (0.8-1.2-1.6-2.0-2.5), time intensity:5-30(step by 5 min) . It will be applied for both groups for 10 minutes

myofascial induction and direct scar release techniques grouptherapeutic ultrasound group

Manual therapy techniques used to reduce chronic lower transverse abdominal scars pain and improve quality of life of the affected women

myofascial induction and direct scar release techniques group

Eligibility Criteria

Age25 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women with a well healed, old , transverse cesarean section scar (more than 6 months resulted in chronic scar pain).
  • Pain can be intermittent or constant at rest or with activity, and it is reported to be at least at a level of about 3/ 10 on visual analogue scale at recording sites will be marked on the C-section scar at 2.5 cm intervals (Wasserman et al., 2018).
  • Women identified that the pain is either located in the cesarean section scar or caused by palpation of scar and it presents since the time of surgery not prior to the cesarean section.
  • Their ages will range from 25-35 years old.
  • Their BMI will be 18.5-29.9 kg/ m².

You may not qualify if:

  • Acute and subacute cesarean section.
  • Delayed wound healing.
  • History of abdominal or pelvic cancer.
  • Active pelvic or abdominal infection.
  • Skin irritation/inflammation at the site of scar.
  • Currently pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Ultrasonic Therapy

Intervention Hierarchy (Ancestors)

DiathermyHyperthermia, InducedTherapeutics

Study Officials

  • Manal M El-shafei, PHD

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Manal El- shafei, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of physical therapy for women's health , faculty of physical therapy

Study Record Dates

First Submitted

June 30, 2023

First Posted

July 10, 2023

Study Start

July 5, 2023

Primary Completion

October 1, 2023

Study Completion

November 1, 2023

Last Updated

July 14, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, ICF